Desensitization by different strategies of epidermal growth factor receptor and ErbB4

Hideyuki Yamamoto1, Sayomi Higa-Nakamine, Nobuhiro Noguchi

  • 1Department of Biochemistry, Graduate School of Medicine, University of the Ryukyus, Japan.

Insights

Epidermal growth factor receptor (EGFR) and ErbB4 desensitization differ; EGFR uses endocytosis, while ErbB4 undergoes cleavage. Understanding these distinct mechanisms is crucial for neuronal development and function.

Area of Science:

  • Cellular Biology
  • Neuroscience
  • Molecular Biology

Background:

  • The ErbB protein family, including EGFR and ErbB4, are transmembrane tyrosine kinases with similar activation mechanisms.
  • Distinct homologous desensitization pathways exist: EGFR desensitizes via endocytosis, whereas ErbB4 desensitizes through cell-surface cleavage.
  • ErbB4 is highly expressed in neurons, making its desensitization mechanism critical for understanding brain development and synaptic function.

Purpose of the Study:

  • To review recent advances in understanding the desensitization mechanisms of EGFR and ErbB4.
  • To highlight the differences in homologous and heterologous desensitization pathways for EGFR and ErbB4.
  • To emphasize the importance of ErbB4 desensitization in neuronal contexts.

Main Methods:

  • Review of existing literature on ErbB receptor desensitization.
  • Focus on studies involving alveolar epithelial cells (for EGFR) and hypothalamic neurons (for ErbB4).
  • Discussion of signaling pathways involved, including p38 MAP kinase and protein kinase C.

Main Results:

  • Homologous desensitization of EGFR involves endocytosis, while ErbB4 involves selective cell-surface cleavage.
  • Heterologous desensitization mirrors homologous pathways: EGFR via endocytosis and ErbB4 via cleavage.
  • EGFR desensitization is linked to serine phosphorylation via the p38 MAP kinase pathway.
  • ErbB4 cleavage is associated with the protein kinase C pathway.

Conclusions:

  • EGFR and ErbB4 exhibit divergent desensitization mechanisms, impacting cellular responses.
  • These distinct pathways are conserved in both homologous and heterologous desensitization.
  • Elucidating these mechanisms provides insight into EGFR function in epithelial cells and ErbB4 function in neurons.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.4K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.4K